p53 fusion protein (GeneCopoeia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namep53 fusion protein (GeneCopoeia)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor protein p53 modulators
TargetsTumor protein p53
Therapy Area/IndicationsPancreatic NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeneCopoeia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneCopoeia Inc
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsLiver Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A